Recent legal challenges to the Trump Administration’s tariff agenda have generated heightened uncertainty within the trade environment, and companies are encouraged to take note. On May 28, 2025, the US Court of...more
The Trump Administration issued a notice on Monday titled, “Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients,” which could serve...more
4/17/2025
/ Imports ,
International Emergency Economic Powers Act (IEEPA) ,
International Trade ,
National Security ,
Pharmaceutical Industry ,
Public Comment ,
Regulatory Requirements ,
Section 232 ,
Supply Chain ,
Tariffs ,
Trump Administration
On Wednesday, April 2, 2025, President Donald Trump held a press conference to describe and sign an Executive Order (EO) establishing sweeping “reciprocal tariffs” on nearly all imports to the US, as outlined below....more